# Nutrition and diets in primary biliary cholangitis
Primary biliary cholangitis (PBC) is a chronic liver disease characterised by damage to the bile ducts and impaired fat metabolism. Nutrition plays a supportive role in the disease process, particularly because the disease can impair the absorption of fats and fat-soluble vitamins. Research data and clinical experience point to several nutritional patterns and substances relevant to PBC.
Protein-rich nutrition
ResearchediPositive results in clinical studies, not yet standard treatment
A diet with adequate protein is important because PBC patients sometimes lose muscle tissue, particularly as liver disease progresses. Protein serves as building material for the repair and maintenance of muscle mass, which is important for overall functioning and vitality.
Research into nutrition and training interventions in liver disease shows that combining adequate protein intake with physical activity can be beneficial for preserving muscle tissue. This is significant because muscle wasting (cachexia) can be a common complication in progressive liver disease.
Recent studies (2026) show that nutritional status and nutritional index can predict how well patients respond to standard treatment. This underscores the importance of adequate nutrition as a supportive element.
Risks are limited, but because PBC can be accompanied by reduced appetite and digestive problems, it can be difficult to get enough protein.
Serine-enriched diet
ExperimentaliOngoing in study setting, outcome still unknown
Serine is an amino acid that plays a role in fat metabolism and cellular processes. Research from 2026 investigated whether serine supplementation has an effect on certain inflammatory pathways in the liver in PBC.
In laboratory studies, serine intake appeared to potentially inhibit certain inflammatory routes (notably the AKT/mTOR signalling pathway in liver macrophages), which in principle could be beneficial for PBC. However, research is still in an early stage; it is unknown whether these effects occur to the same extent in humans, and what quantities would be needed.
This diet is therefore classified as experimental. It is not yet part of standard treatment.
Vitamin and mineral enrichment (vitamin D, folate, vitamin B6)
ResearchediPositive results in clinical studies, not yet standard treatment
Because PBC can limit the absorption of fat-soluble vitamins (A, D, E, K), many patients experience gaps in their nutritional pattern. Recent studies focus on a few specific nutrients:
**Vitamin D:** Studies show that vitamin D supplementation in patients with related cholestasis (primary sclerosing cholangitis) is associated with a lower risk of liver and bile duct disease. Although this research does not directly focus on PBC, the biological mechanisms are similar. Vitamin D plays a role in immune regulation, which is relevant for an autoimmune disease such as PBC.
**Folate:** Research from 2026 indicates that folate deficiency is associated with more severe PBC symptoms and may be linked to changes in genes important for disease control. This suggests that a diet with adequate folate (leafy greens, legumes, grain products) may be beneficial.
**Vitamin B6:** Studies in related cholestasis conditions show that low B6 levels are predictive of poorer outcomes. Although research specific to PBC is still ongoing, this points to the importance of adequate intake.
Obtaining these vitamins and minerals through food is preferred; supplementation is done under the guidance of your healthcare provider, as dosing depends on individual deficiencies and blood values.
Mediterranean dietary pattern
ResearchediPositive results in clinical studies, not yet standard treatment
The Mediterranean dietary pattern – plenty of vegetables, fruit, whole grains, fish, nuts and olive oil – has been extensively studied in liver disease. This pattern is known for its anti-inflammatory and beneficial effects on fat metabolism.
For PBC specifically, large randomized trials are limited, but the pattern aligns well with cholestasis recommendations: it promotes healthy gut microbiota composition, supports antioxidant absorption, and provides nutrition with low inflammatory potential. This may help limit liver inflammation.
No known risks; this pattern is generally considered safe and supportive in chronic liver disease.
Limiting simple sugars and refined carbohydrates
ResearchediPositive results in clinical studies, not yet standard treatment
Many patients with PBC develop liver fat (steatosis) alongside their autoimmune disease. Limiting simple sugars and refined carbohydrates can slow fat accumulation in the liver, not only because it moderately reduces calorie intake, but also because it promotes insulin sensitivity.
Studies in liver and metabolic disorders show that diets lower in refined carbohydrates and higher in nutritious structural carbohydrates can be beneficial for liver fat content and inflammation markers.
No specific risks; on the contrary, this aligns with preventive care.
Fat restriction in severe bile-related symptoms
ResearchediPositive results in clinical studies, not yet standard treatment
When PBC is accompanied by severe abdominal complaints, diarrhea, or poor fat digestion, a diet with limited fat (especially less animal fat) may be useful for symptom relief. This is not because fat is inherently harmful to the liver, but because it can simplify intake and relieve intestinal complaints when bile production is disrupted.
This approach is individual; not all PBC patients benefit from it, and it serves short-term symptom management, not disease course. Long-term strict fat restriction can lead to deficiencies in fat-soluble vitamins.
Nutritional interventions in advanced disease and cirrhosis
ResearchediPositive results in clinical studies, not yet standard treatment
As PBC progresses, patients may develop complications such as portal hypertension and possible muscle wasting. At this stage, nutritional interventions focus on muscle screening, adequate protein intake, and sometimes supportive nutrition.
Studies from 2026 emphasize the importance of metabolism and nutritional status as predictors of treatment response and outcomes. Nutrition is not a cure, but it does support the body's ability to better manage the disease and medication.
---
Nutritional choices in primary biliary cholangitis are individualized. Each person responds differently to nutritional interventions, and what helps with symptom relief varies greatly. Many patients notice differences in fatigue, abdominal complaints, or overall well-being based on nutritional choices, but this is highly personal. A specialized dietitian, preferably with knowledge of liver disease, can help you develop a nutrition plan that aligns with your disease stage, symptoms, and treatment. Nutrition works alongside medication; they do not replace each other. All decisions about nutrition should be discussed with your healthcare provider or dietitian.
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._